Literature DB >> 26226213

Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study.

Faisal Rahman1, Na Wang2, Xiaoyan Yin3, Patrick T Ellinor4, Steven A Lubitz4, Paul A LeLorier5, David D McManus6, Lisa M Sullivan3, Sudha Seshadri7, Ramachandran S Vasan8, Emelia J Benjamin9, Jared W Magnani10.   

Abstract

BACKGROUND: Few epidemiologic cohort studies have evaluated atrial flutter (flutter) as an arrhythmia distinct from atrial fibrillation (AF).
OBJECTIVE: The purpose of this study was to examine the clinical correlates of flutter and its associated outcomes to distinguish them from those associated with AF in the Framingham Heart Study.
METHODS: We reviewed and adjudicated electrocardiograms (ECGs) previously classified as flutter or AF/flutter and another 100 ECGs randomly selected from AF cases. We examined the clinical correlates of flutter by matching up to 5 AF and 5 referents to each flutter case using a nested case referent design. We determined the 10-year outcomes associated with flutter with Cox models.
RESULTS: During mean follow-up of 33.0 ± 12.2 years, 112 participants (mean age 72 ± 10 years, 30% women) developed flutter. In multivariable analyses, smoking (odds ratio [OR] 2.84, 95% confidence interval [CI] 1.54-5.23), increased PR interval (OR 1.28 per SD, 95% CI 1.03-1.60), myocardial infarction (OR 2.25, 95% CI 1.05-4.80) and heart failure (OR 5.22, 95% CI 1.26-21.64) were associated with incident flutter. In age- and sex-adjusted models, flutter (vs referents) was associated with 10-year increased risk of AF (hazard ratio [HR] 5.01, 95% CI 3.14-7.99), myocardial infarction (HR 3.05, 95% CI 1.42-6.59), heart failure (HR 4.14, 95% CI 1.90-8.99), stroke (HR 2.17, 95% CI 1.13-4.17), and mortality (HR 2.00, 95% CI 1.44-2.79).
CONCLUSION: We identified the clinical correlates associated with flutter and observed that flutter was associated with multiple adverse outcomes.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Atrial flutter; Epidemiology; Outcomes; Risk factors

Mesh:

Year:  2015        PMID: 26226213      PMCID: PMC4698205          DOI: 10.1016/j.hrthm.2015.07.031

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  37 in total

1.  Electrocardiographic differentiation of atrial flutter from atrial fibrillation by physicians.

Authors:  B P Knight; G F Michaud; S A Strickberger; F Morady
Journal:  J Electrocardiol       Date:  1999-10       Impact factor: 1.438

2.  Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter.

Authors:  Jessica Voight; Mehmet Akkaya; Porur Somasundaram; Rehan Karim; Salimah Valliani; Younghoon Kwon; Selcuk Adabag
Journal:  Heart Rhythm       Date:  2014-07-01       Impact factor: 6.343

3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

4.  Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Società Italiana di Ecografia Cardiovascolare) multicentre study.

Authors:  G Corrado; A Sgalambro; A Mantero; F Gentile; M Gasparini; R Bufalino; A Morabito; G Trocino; R Schiavina; S Mandorla; R Mangia; D Tovena; K Savino; F Jacopi; E M Pellegrino; F Agostini; G Centonze; F Bovenzi; E Caprino; G Tadeo; M Santarone
Journal:  Eur Heart J       Date:  2001-06       Impact factor: 29.983

5.  Incidence and predictors of atrial flutter in the general population.

Authors:  J Granada; W Uribe; P H Chyou; K Maassen; R Vierkant; P N Smith; J Hayes; E Eaker; H Vidaillet
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

6.  Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study.

Authors:  Jared W Magnani; Na Wang; Kerrie P Nelson; Stephanie Connelly; Rajat Deo; Nicolas Rodondi; Erik B Schelbert; Melissa E Garcia; Caroline L Phillips; Michael G Shlipak; Tamara B Harris; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-12-16

7.  Atrial fibrillation and the risk of myocardial infarction.

Authors:  Elsayed Z Soliman; Monika M Safford; Paul Muntner; Yulia Khodneva; Farah Z Dawood; Neil A Zakai; Evan L Thacker; Suzanne Judd; Virginia J Howard; George Howard; David M Herrington; Mary Cushman
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

8.  Electrocardiographic PR prolongation and atrial fibrillation risk: a meta-analysis of prospective cohort studies.

Authors:  Min Cheng; Xiangfeng Lu; Jianfeng Huang; Shu Zhang; Dongfeng Gu
Journal:  J Cardiovasc Electrophysiol       Date:  2014-09-26

9.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.

Authors:  Renate B Schnabel; Xiaoyan Yin; Philimon Gona; Martin G Larson; Alexa S Beiser; David D McManus; Christopher Newton-Cheh; Steven A Lubitz; Jared W Magnani; Patrick T Ellinor; Sudha Seshadri; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy
Journal:  Lancet       Date:  2015-05-07       Impact factor: 79.321

10.  Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.

Authors:  Alvaro Alonso; Bouwe P Krijthe; Thor Aspelund; Katherine A Stepas; Michael J Pencina; Carlee B Moser; Moritz F Sinner; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Sunil K Agarwal; David D McManus; Patrick T Ellinor; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Elsayed Z Soliman; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2013-03-18       Impact factor: 5.501

View more
  14 in total

Review 1.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

2.  Characterization of atrial flutter after pulmonary vein isolation by cryoballoon ablation.

Authors:  Jayson R Baman; Rachel M Kaplan; Celso L Diaz; Graham Peigh; Aakash A Bavishi; Amar Trivedi; Jeremiah Wasserlauf; Alexandru B Chicos; Rishi Arora; Susan Kim; Albert Lin; Nishant Verma; Bradley P Knight; Rod S Passman
Journal:  J Interv Card Electrophysiol       Date:  2019-05-17       Impact factor: 1.900

3.  Differences in Stroke or Systemic Thromboembolism Readmission Risk After Hospitalization for Atrial Fibrillation and Atrial Flutter.

Authors:  Harshith S Thyagaturu; Alexander Bolton; Sittinun Thangjui; Kashyap Shah; Bishesh Shrestha; Dinesh Voruganti; Daniel Katz
Journal:  Cureus       Date:  2022-04-05

4.  Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter-a View From a National Cohort Study.

Authors:  Yu-Sheng Lin; Tien-Hsing Chen; Ching-Chi Chi; Ming-Shyan Lin; Tao-Hsin Tung; Chi-Hung Liu; Yung-Lung Chen; Mien-Cheng Chen
Journal:  J Am Heart Assoc       Date:  2017-07-21       Impact factor: 5.501

5.  Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis.

Authors:  Wenqi He; Yingjie Chu
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

6.  Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Naqash J Sethi; Sanam Safi; Joshua Feinberg; Emil E Nielsen; Christian Gluud; Janus C Jakobsen
Journal:  Syst Rev       Date:  2017-04-05

7.  The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Naqash J Sethi; Sanam Safi; Emil E Nielsen; Joshua Feinberg; Christian Gluud; Janus C Jakobsen
Journal:  Syst Rev       Date:  2017-03-06

Review 8.  Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Authors:  Naqash J Sethi; Emil E Nielsen; Sanam Safi; Joshua Feinberg; Christian Gluud; Janus C Jakobsen
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

9.  Diagnosis and Management of 1:1 Atrial Flutter in the Setting of Aortic Valve Endocarditis and Embolic Stroke.

Authors:  Bisrat Nigussie; Fuad I Abaleka; Maham Suhail; Esmael Yimer; Francesco Rotatori
Journal:  Cureus       Date:  2020-06-21

Review 10.  The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Naqash J Sethi; Joshua Feinberg; Emil E Nielsen; Sanam Safi; Christian Gluud; Janus C Jakobsen
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.